PTPI
Petros Pharmaceuticals, Inc.
OTCHealthcareDrug Manufacturers - Specialty & GenericUS
Rating:A-
Company Profile
CEO
Fady Boctor
IPO Date
2020-12-02
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
OTC
Country
US
Petros Pharmaceuticals, Inc.
CEO
Fady Boctor
IPO Date
2020-12-02
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
OTC
Country
US
| 375,000 |
| $0.00 |
| 5 Jun 2026 | Boctor Fady | See Remarks | A-Award | Acquired | 375,000 | $0.00 |
| 5 Jun 2026 | Bernstein Bruce | director | A-Award | Acquired | 1,875,000 | $0.00 |
| 5 Jun 2026 | Silverman Joshua | director | A-Award | Acquired | 4,375,000 | $0.00 |
| 6 Jan 2026 | Boctor Fady | See Remarks | A-Award | Acquired | 500,000 | $0.00 |
| 2 Jan 2026 | Silverman Joshua | director | A-Award | Acquired | 4,375,000 | $0.00 |
| 2 Jan 2026 | WALKER WAYNE REMELL | director | A-Award | Acquired | 500,000 | $0.00 |
| 2 Jan 2026 | Bernstein Bruce | director | A-Award | Acquired | 1,875,000 | $0.00 |
| 21 Feb 2025 | Bernstein Bruce | director | A-Award | Acquired | 300,000 | $0.00 |